BTIG Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $58

BTIG analyst Julian Harrison initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $58.